Cargando…

Study of Modifications Induced by Continued Direct Oral Anticoagulant Therapy during Atrial Fibrillation Ablation Procedures on Standard Hemostasis Parameters

Background: Unfractionated heparin (UFH) is used as an anticoagulant during the atrial fibrillation (AF) ablation procedure to prevent the occurrence of thromboembolic events. Guidelines recommend an activated clotting time (ACT) greater than 300 s (s) based on studies of patients treated with vitam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muller, Marie, Godet, Julien, Delabranche, Xavier, Sattler, Laurent, Millard, David, Marzak, Halim, Mertes, Paul Michel, Steib, Annick, Grunebaum, Lelia, Jesel, Laurence, Tacquard, Charles Ambroise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054854/ https://www.ncbi.nlm.nih.gov/pubmed/36983237 http://dx.doi.org/10.3390/jcm12062236

Ejemplares similares

Delayed pulmonary embolism after COVID-19 pneumonia: a case report
por: Kanso, Mohamad, et al.
Publicado: (2020)

High-grade atrioventricular block occurring during percutaneous closure of patent foramen ovale: a case report
por: Kibler, Marion, et al.
Publicado: (2020)

An unusual case of dilated coronary sinus: case report and clinical implications
por: Cardi, Thomas, et al.
Publicado: (2021)

Impact of gender on left atrial low-voltage zones in patients with persistent atrial fibrillation: results of a voltage-guided ablation
por: Marzak, Halim, et al.
Publicado: (2023)

COVID-19 Related Coagulopathy: A Distinct Entity?
por: Marchandot, Benjamin, et al.
Publicado: (2020)

Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR
por: Dietrich, Laurent, et al.
Publicado: (2021)

Figure-of-eight suture for venous hemostasis in fully anticoagulated patients after atrial fibrillation catheter ablation
por: Lakshmanadoss, Umashankar, et al.
Publicado: (2017)

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
por: Helms, Julie, et al.
Publicado: (2020)

Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent
por: Vollmer, Olivier, et al.
Publicado: (2021)

Management of a superinfected pyoderma gangrenosum after pacemaker implant
por: Marzak, Halim, et al.
Publicado: (2018)

Platelet dysfunction and thrombus instability in flow conditions in patients with severe COVID-19
por: Tacquard, Charles, et al.
Publicado: (2023)

Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia
por: Tacquard, Charles, et al.
Publicado: (2021)

Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring
por: Susen, Sophie, et al.
Publicado: (2020)

Comparison of peri-procedural anticoagulation with rivaroxaban and apixaban during radiofrequency ablation of atrial fibrillation
por: Pillarisetti, Jayasree, et al.
Publicado: (2020)

Microparticles in COVID-19 as a link between lung injury extension and thrombosis
por: Morel, Olivier, et al.
Publicado: (2021)

Epileptic seizure-induced syncopal asystole reversed by lacosamide: a case report
por: Fitouchi, S, et al.
Publicado: (2022)

Baseline mean platelet volume is a strong predictor of major and life-threatening bleedings after transcatheter aortic valve replacement
por: Trimaille, Antonin, et al.
Publicado: (2021)

L-62 Transfusion et patients COVID-19 au cours de la 1(ère) vague
por: Delabranche, Xavier, et al.
Publicado: (2022)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011)

Transient endothelial injury and release of lupus anticoagulant in COVID-19
por: Trimaille, Antonin, et al.
Publicado: (2021)

Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis
por: Grover, Steven P., et al.
Publicado: (2022)

Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
por: Winkle, Roger A., et al.
Publicado: (2014)

Acute Pulmonary Embolism in Patients with and without COVID-19
por: Trimaille, Antonin, et al.
Publicado: (2021)

Femoral venous hemostasis after atrial fibrillation ablation: Is figure-of-eight suture the way to go?
por: Batul, Syeda Atiqa, et al.
Publicado: (2017)

L-63 Anticoagulation des patients COVID : risque hémorragique et thrombotique
por: Tacquard, Charles
Publicado: (2022)

Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study
por: Helms, Julie, et al.
Publicado: (2021)

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
por: van Vugt, S. P. G., et al.
Publicado: (2018)

D-Dimers Level as a Possible Marker of Extravascular Fibrinolysis in COVID-19 Patients
por: Trimaille, Antonin, et al.
Publicado: (2020)

Peri-procedural anticoagulation in patients with end-stage kidney disease undergoing atrial fibrillation ablation: results from the multicentre end-stage kidney disease–atrial fibrillation ablation registry
por: Yamamoto, Tasuku, et al.
Publicado: (2023)

Vaccine-induced immune thrombotic thrombocytopenia: current evidence, potential mechanisms, clinical implications, and future directions
por: Marchandot, Benjamin, et al.
Publicado: (2021)

Knots to untie: anticoagulant and antiarrhythmic therapy after ablation for atrial fibrillation
por: Stazi, Filippo
Publicado: (2020)

Effects of uninterrupted dabigatran on the intensity of anticoagulation during atrial fibrillation ablation
por: Osawa, Takumi, et al.
Publicado: (2021)

Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
por: Gjermeni, Diona, et al.
Publicado: (2023)

Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
por: Murakawa, Yuji, et al.
Publicado: (2017)

Ablation of atrial fibrillation: a procedure come of age?
por: Wharton, J Marcus
Publicado: (2001)

Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation
por: Tóth, Noémi Klára, et al.
Publicado: (2017)

Safety of catheter ablation of atrial fibrillation without pre‐ or peri‐procedural imaging for the detection of left atrial thrombus in the era of uninterrupted anticoagulation
por: Efremidis, Michael, et al.
Publicado: (2020)

Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes
por: Winkle, Roger A., et al.
Publicado: (2013)

Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2015)

Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Maraj, Ilir, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k26u5snj6ufs72jd62ooqnq68j